Title | Description |
|---|---|
| Trial ID | KF5503-73 |
| Compound | Tapentadol |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 2 |
| Brief title | Use of intravenous tapentadol solution for injection for pain after surgery in children from newborn to less than 2 years old, including preterm babies |
| Indication | Pain in Children, acute pain, post-operative pain |
| UTN | U1111-1157-3228 |
| CTG ID | |
| CTIS ID (former EudraCT) | 2014-002259-24 |
| Trial status | Completed |
| FPI | April 23, 2015 |
| LPO | September 27, 2018 |
| Countries | Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Spain, Austria, Croatia, Slovakia, United Kingdom, Netherlands |
| Gender | All |
| Age | >= 18 years of age |
| Results | Yes |
| Pubmed | |
| Documents | kf5503-73-expert-summary kf5503-73-lay-summary-english kf5503-73-lay-summary-french kf5503-73-lay-summary-hungarian kf5503-73-lay-summary-polish kf5503-73-lay-summary-spanish |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.